InvestorsHub Logo

noblynx

02/13/21 6:18 AM

#3903 RE: -3 #3902

Thanks, -3!

To quote that release partially...

Toronto, Ontario – August 19, 2020, Theralase® Technologies Inc... announced today that it has executed a Sponsored Research Agreement with the University of Manitoba Medical Microbiology department to commence development of a coronavirus vaccine and therapy utilizing Theralase’s patented and proprietary PDCs... [the approach] to be further evaluated in animal then human clinical testing in 2021.

We're still awful early in 2021, but probably (for rats) not too early to see some valid, positive initial results, given what could well be a "live or die" so-called "endpoint" evaluation.